89bio, Inc. - Common stock, par value $0.001 per share (ETNB)
CUSIP: 282559103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 148,275,293
- Total 13F shares
- 103,292,520
- Share change
- +5,002,764
- Total reported value
- $827,294,025
- Put/Call ratio
- 1851%
- Price per share
- $8.01
- Number of holders
- 142
- Value change
- +$24,658,190
- Number of buys
- 84
- Number of sells
- 65
Quarterly Holders Quick Answers
What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 282559103:
Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
8.6%
|
12,766,948
|
$148,607,275 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
8.5%
|
12,603,382
|
$146,646,215 | — | 31 Mar 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5%
|
7,378,548
|
$85,886,299 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
6,637,984
|
$77,266,133 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.2%
|
6,298,004
|
$73,308,767 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.7%
|
5,543,588
|
$64,527,364 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
4,722,971
|
$54,975,382 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
2.7%
|
4,047,354
|
$47,111,201 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.5%
|
3,710,191
|
$43,186,623 | — | 31 Mar 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.3%
|
3,450,689
|
$40,166,020 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
1.8%
|
2,699,470
|
$31,421,831 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
1.5%
|
2,264,566
|
$26,359,548 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.5%
|
2,164,147
|
$25,190,671 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,829,436
|
$21,093,397 | — | 25 Jan 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,740,867
|
$20,267,018 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
1,569,542
|
$18,269,469 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.73%
|
1,087,197
|
$12,654,973 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
0.67%
|
1,000,000
|
$11,640,000 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.65%
|
967,742
|
$11,264,517 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.63%
|
941,287
|
$10,956,580 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.56%
|
827,657
|
$9,633,927 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.55%
|
812,622
|
$9,458,925 | — | 31 Mar 2024 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.51%
|
749,350
|
$8,722,434 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
744,948
|
$8,671,195 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
714,531
|
$8,317,141 | — | 31 Mar 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.45%
|
673,000
|
$7,799,730 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
629,233
|
$7,324,272 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.46%
|
679,767
|
$7,293,899 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
550,594
|
$6,408,914 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.35%
|
515,882
|
$6,004,866 | — | 31 Mar 2024 | |
| University of Wisconsin Foundation |
13F
|
Company |
0.34%
|
498,137
|
$5,798,315 | — | 31 Mar 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.32%
|
470,387
|
$5,475,305 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.31%
|
461,952
|
$5,377,121 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.3%
|
450,000
|
$5,238,000 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.28%
|
418,259
|
$4,868,535 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
408,639
|
$4,756,557 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.24%
|
354,088
|
$4,121,585 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
320,732
|
$3,733,320 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.21%
|
310,000
|
$3,608,400 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.21%
|
307,924
|
$3,584,236 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.2%
|
300,000
|
$3,492,000 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.2%
|
300,000
|
$3,492,000 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.17%
|
250,000
|
$2,910,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
248,746
|
$2,895,403 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.17%
|
246,100
|
$2,864,604 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.16%
|
231,007
|
$2,688,921 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
179,962
|
$2,094,758 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.12%
|
179,899
|
$2,094,024 | — | 31 Mar 2024 | |
| COMERICA BANK |
13F
|
Company |
0.12%
|
171,000
|
$1,990,440 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
147,200
|
$1,713,408 | — | 31 Mar 2024 |
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2024
As of 30 Jun 2024,
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,292,520 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, SUVRETTA CAPITAL MANAGEMENT, LLC, BVF INC/IL, RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, Pictet Asset Management Holding SA, STATE STREET CORP, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
147
Q2 2024 holders
142
Holder diff
-5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.